New Delhi, Sept. 27 -- In a dramatic development, the US President Donald Trump announced 100% conditional tariffs on the pharma imports from 1st October 2025. The US President made this announcement on Thursday from his social media handle, which triggered panic selling on Friday in the pharma segment. Indian Pharma majors, especially Sun Pharma, Aurobindo Pharma, Cipla, Dr Reddy's Lab, Gland Pharma, Zydus Life and Lupin, account for around 70% of the drugs exported to the US. However, stock market experts believe that Indian pharma companies may see a sharp turnaround on Monday as they are expected to escape the latest Trump tariff shock. They said that a 100% tariff on pharma imports is conditional, as it will be levied on the patent a...